• FDA Eyes Earlier Drug Treatments for Alzheimer’s
Evolving theories around the progression of Alzheimer’s disease have led the F.D.A. to draft potential new guidelines that would permit pharmaceutical treatments for patients at an earlier stage of the...
View Article• FDA Lays Down New Food Safety Rules
After extensive consultations with global regulatory partners, farmers, industry stakeholders, members of the research community and various officials, the FDA has proposed two new food safety rules....
View Article• Azithromycin May be Associated with Fatal Heart Rhythm
A commonly prescribed antibiotic ”azithromycin” or “Zithromax” has been found to cause fatal heart rhythm problems and the FDA has issued a warning regarding its use. The warning by the FDA comes...
View Article• FDA Plans to Loosen Rules for Approving Alzheimer’s Drugs
In a move that was met with widespread approval from Big Pharma, the FDA announced that it plans to loosen the regulations for approving new treatments for Alzheimer’s disease. The shift could be a...
View ArticleFDA Commissioner Rails Against Budget Cuts
In a hearing with a Senate subcommittee this week, FDA Commissioner Margaret Hamburg asked for additional funding to counter the $209 million in mandatory cuts to agency that were made as a part of the...
View ArticleClik here to view.
Alzheimer’s Drug Trials Ended
Baxter International said it was ending clinical trials for Gammagard, a treatment for Alzheimer’s disease that once showed great potential. “The study missed its primary endpoints,” Ludwig Hantson,...
View ArticleClik here to view.
Breast Implants Found to be Associated with Cancer
Cosmetic breast implants are becoming increasingly common. According to the latest statistics, almost 307,000 breast augmentation surgeries were done in the U.S. in 2011. This makes them one of the...
View ArticleClik here to view.
HbA1c a New Tool for Diagnosing Diabetes
HbA1c is a widely used marker of chronic blood glucose levels, reflecting average values over a two to three month period. The test plays a critical role in the management of the patient with diabetes...
View ArticleClik here to view.
FDA Warns Against the Use of Magnesium to Prevent Preterm Labor
The FDA has issued an advisory to clinicians against using magnesium sulfate for more than 5 to 7 days to prevent preterm labor. This has been done in the wake of the findings by the Adverse Event...
View ArticleClik here to view.
FDA Relaxes Avandia Restrictions
Courtesy www.npr.org A panel of Food and Drug Administration experts voted to relax regulations on a controversial diabetes drug that the government agency had voted to remove form the market in 2010...
View Article